Core Viewpoint - The company, Huizhong Co., has experienced a decline in the number of shareholders for the second consecutive period, indicating potential concerns regarding investor confidence and stock performance [2]. Group 1: Shareholder Information - As of July 31, the number of shareholders for Huizhong Co. was 12,978, a decrease of 1,460 from the previous period (July 20), representing a decline of 10.11% [2]. - This marks the second consecutive decline in the number of shareholders for the company [2]. Group 2: Stock Performance - The closing price of Huizhong Co. was 12.80 yuan, reflecting an increase of 1.67%. Since the concentration of shares began, the stock price has cumulatively risen by 0.87% [2]. - The stock experienced five days of increases and five days of decreases during the reporting period [2]. Group 3: Financial Performance - In the first quarter, Huizhong Co. achieved operating revenue of 73.6493 million yuan, a year-on-year increase of 47.52%, and a net profit of 6.9693 million yuan, up 71.77% year-on-year [2]. - The basic earnings per share were 0.0350 yuan, with a weighted average return on equity of 0.62% [2]. - The company released a half-year performance forecast on July 9, estimating a net profit between 39.9762 million yuan and 42.0262 million yuan, with a variation range of 95.00% to 105.00% [2].

Group 1 - The stock price of Huizhong Co., Ltd. is reported at 13.06 yuan, down 1.28% from the previous trading day [1] - The company operates in the instrumentation industry, focusing on the research and application of ultrasonic flow measurement technology, with products including ultrasonic water meters and ultrasonic heat meters [1] - The company expects a net profit of 39.9762 million to 42.0262 million yuan for the first half of 2025, representing a year-on-year growth of 95% to 105% [1] Group 2 - As of July 20, the number of shareholders in Huizhong Co., Ltd. was 14,438, a decrease of 24.28% compared to July 10 [1] - On July 29, the net outflow of main funds for Huizhong Co., Ltd. was 9.1005 million yuan, accounting for 0.52% of the circulating market value [1]

Group 1 - A total of 390 stocks reported their latest shareholder numbers as of July 20, with 188 stocks showing a decrease compared to the previous period [1][3] - The stocks with the largest decline in shareholder numbers include Chuangyitong, Huizhong Co., and Xingsen Technology, with declines of 27.39%, 24.28%, and 18.87% respectively [3][4] - The average increase in the concentrated chip stocks since July 1 is 4.56%, outperforming the Shanghai Composite Index, which increased by 3.99% [2] Group 2 - Among the stocks with a decline of over 10% in shareholder numbers, 19 stocks were identified, with Huicheng Co. showing the highest increase in stock price at 41.92% since July 1 [2][3] - The latest performance report indicates that four stocks have already released their half-year earnings, with Baolong Chuangyuan and Guoyuan Securities showing net profit growth rates of 42.68% and 40.44% respectively [4] - The industry distribution of concentrated chip stocks shows a significant presence in machinery, basic chemicals, and electronics, with 25, 22, and 13 stocks respectively [3][4]

Group 1 - A total of 122 companies listed on the ChiNext board reported their latest shareholder numbers as of July 20, with 55 companies experiencing a decline in shareholder numbers compared to the previous period [1] - Among the companies with the largest decline in shareholder numbers, Chuangyitong saw a decrease of 27.39%, while Huizhong Co. experienced a decline of 24.28% [1][3] - The average increase in share prices for concentrated chip stocks since July 11 is 1.49%, with notable gainers including Top Cloud Agriculture, Demai Technology, and Antarctic Light, which rose by 21.29%, 10.96%, and 10.25% respectively [2] Group 2 - Four companies on the ChiNext board have announced positive profit forecasts for the first half of the year, with Huizhong Co. expecting a net profit increase of 100% [3] - The companies with the most significant cumulative declines in shareholder numbers over three consecutive periods include Yanggu Huatai, with a total decline of 24.89%, and Baichuan Qiancheng, with a decline of 18.54% [2][4] - The sectors with the highest concentration of stocks include pharmaceuticals, computers, and machinery, each with six companies listed [2]

Core Insights - 26 companies listed on the ChiNext board have released their performance forecasts for the first half of the year, with 19 companies expecting profit increases, representing 73.08% of the total [1] - The overall proportion of companies reporting positive forecasts is 80.77%, with 2 companies expecting profits and 1 company forecasting losses [1] Performance Forecast Summary - Among the companies with positive forecasts, 7 are expected to see net profit growth exceeding 100%, while 4 companies anticipate growth between 50% and 100% [1] - Han Yu Pharmaceutical is projected to have the highest net profit growth, with a median increase of 1567.36% [1] - Other notable companies include Chuanjin Nuo and Longyuan Technology, with expected net profit growth of 167.27% and 137.44% respectively [1] Company Performance Highlights - The following companies are highlighted for their significant expected profit increases: - Han Yu Pharmaceutical (Code: 300199) - Expected net profit growth: 1567.36%, Latest closing price: 18.24, Year-to-date change: 41.51%, Industry: Pharmaceutical [1] - Chuanjin Nuo (Code: 300505) - Expected net profit growth: 167.27%, Latest closing price: 19.95, Year-to-date change: 40.94%, Industry: Basic Chemicals [1] - Longyuan Technology (Code: 300105) - Expected net profit growth: 137.44%, Latest closing price: 8.11, Year-to-date change: 7.79%, Industry: Environmental Protection [1] - Other companies with notable growth include Chenguang Biotech, Feirongda, Boteng Co., and Huizhong Co. [1]

Group 1 - A total of 18 companies listed on the ChiNext board have released their performance forecasts for the first half of the year, with 13 companies expecting profit increases, 1 company expecting to turn a profit, 1 company expecting a profit decrease, and 1 company expecting a loss [1][3] Group 2 - The performance forecast details include various companies with significant expected profit growth, such as: - Hanyu Pharmaceutical (300199) with a projected profit increase of 1567.36% [2] - Chuanjin Nuo (300505) with a projected profit increase of 167.27% [2] - Chenguang Biotech (300138) with a projected profit increase of 117.36% [2] - Huizhong (300371) with a projected profit increase of 100.00% [2] - Taotao Automotive (301345) with a projected profit increase of 84.08% [2] Group 3 - Companies with performance forecasts indicating a decrease or loss include: - Zairun (301636) with a projected profit decrease of 5.43% [2] - Yuyou Green Energy (301590) with a projected profit decrease of 6.57% [2] - Juguang (300203) with a projected loss of 205.37% [2]

Group 1 - The company Huizhong Co., Ltd. experienced a 20cm limit-up in stock price [1]

Group 1 - Dazhihui reported that its daily operations are normal and there are no significant changes [4] - Jinchengzi announced that revenue from laser 3D printing control systems will account for less than 2% of total revenue in 2024 [5][6] - Bayi Shikong is expanding into edge computing business [8] - Zhengfan Technology plans to acquire 62.23% stake in Hanjing Semiconductor [10] - Dayang Electric is planning to issue H-shares and list on the Hong Kong Stock Exchange [18] Group 2 - Haitong Development intends to use up to $65 million to purchase dry bulk carriers [2] - Juhua Co. expects a net profit of 1.97 billion to 2.13 billion yuan for the first half of 2025, a year-on-year increase of 136% to 155% [3] - Dajin Heavy Industry anticipates a net profit of 510 million to 570 million yuan for the first half of 2025, a year-on-year increase of 193.32% to 227.83% [11] - Yatai Co. expects a net profit of 190 million to 210 million yuan for the first half of 2025, a year-on-year increase of 81.97% to 101.13% [12] - Huizhong Co. expects a net profit of 39.98 million to 42.03 million yuan for the first half of 2025, a year-on-year increase of 95% to 105% [13]

[Performance Forecast Overview](index=1&type=section&id=Item%20I.%20Current%20Period%20Performance%20Forecast) The company forecasts strong year-over-year growth for H1 2025, with operating revenue up 45%-55% and net profit attributable to shareholders up 95%-105% Key Financial Performance Indicators | Item | Current Reporting Period (Jan 1 – Jun 30, 2025) | Prior Period | | :--- | :--- | :--- | | **Operating Revenue** | CNY 203.9982 million – CNY 218.0670 million | CNY 140.6884 million | | Year-over-Year Growth | 45% - 55% | - | | **Net Profit Attributable to Shareholders of Listed Company** | CNY 39.9762 million – CNY 42.0262 million | CNY 20.5006 million | | Year-over-Year Growth | 95% - 105% | - | | **Net Profit Excluding Non-Recurring Gains and Losses** | CNY 35.1409 million – CNY 36.7754 million | CNY 16.3446 million | | Year-over-Year Growth | 115% - 125% | - | [Pre-Audit Status](index=1&type=section&id=Item%20II.%20Pre-Audit%20Status%20of%20Performance%20Forecast) The financial data in this performance forecast represents preliminary calculations by the company's finance department and remains unaudited by a certified public accountant - The financial data in this performance forecast has not been audited by a certified public accountant[3](index=3&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=Item%20III.%20Explanation%20of%20Performance%20Changes) The company's H1 2025 performance growth is primarily driven by increased overseas sales and a positive contribution from non-recurring gains and losses - The year-over-year growth in operating revenue and net profit is primarily attributed to increased sales in overseas markets[4](index=4&type=chunk) - Non-recurring gains and losses are expected to contribute approximately **CNY 5.20 million** to net profit during the reporting period[5](index=5&type=chunk) [Other Notes and Risk Warning](index=2&type=section&id=Item%20IV.%20Other%20Related%20Notes) The company states this performance forecast is preliminary and unaudited, with final financial data to be disclosed in the 2025 semi-annual report, urging investors to exercise caution - This performance forecast represents preliminary calculations by the company's finance department and has not been audited, with final financial data subject to the 2025 semi-annual report[6](index=6&type=chunk) - The company advises investors to exercise caution in their decisions and be aware of investment risks[6](index=6&type=chunk)

Group 1 - The company Huizhong Co., Ltd. (stock code: 300371) announced an expected revenue of 204 million to 218 million yuan for the period from January 1, 2025, to June 30, 2025, representing a growth of 45% to 55% compared to the same period last year, which was 141 million yuan [1] - The net profit attributable to shareholders of the listed company is expected to be between 39.9762 million and 42.0262 million yuan, an increase of 95% to 105% compared to the same period last year, which was 20.5006 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 35.1409 million and 36.7754 million yuan, reflecting a growth of 115% to 125% compared to the same period last year, which was 16.3446 million yuan [1]